Skip Nav Destination
1-7 of 7
Masaki Naganuma, Masatoshi Koga, Yoshiaki Shiokawa, Jyoji Nakagawara, Eisuke Furui, Kazumi Kimura, Hiroshi Yamagami, Yasushi Okada, Yasuhiro Hasegawa, Kazuomi Kario, Satoshi Okuda, Kazutoshi Nishiyama, Kazuo Minematsu, Kazunori Toyoda
Cerebrovasc Dis (2011) 31 (2): 123–129.
Published Online: 17 November 2010
... dysfunction affects the outcome of stroke patients treated with recombinant tissue plasminogen activator (rt-PA). Methods: A retrospective, multicenter, observational study was conducted to identify the effects of underlying risk factors on intravenous rt-PA therapy using 0.6 mg/kg alteplase in 10 stroke...
Mohamed M. Ibrahim, Joseph Sebastian, Muhammad Hussain, Fawaz Al-Hussain, Ken Uchino, Carlos Molina, Khurshid Khan, Andrew M. Demchuk, Andrei V. Alexandrov, Maher Saqqur, for the CLOTBUST Investigators
Cerebrovasc Dis (2010) 30 (5): 508–513.
Published Online: 22 September 2010
... rate and outcome in acute stroke patients. Methods: We conducted a retrospective analysis of acute stroke patients who received intravenous (IV) recombinant tissue plasminogen activator (rt-PA) and had transcranial Doppler examination within 3 h of symptom onset. The TCD findings were interpreted using...
Cerebrovasc Dis (2009) 28 (5): 460–467.
Published Online: 08 September 2009
...Yasuyuki Iguchi; Kazumi Kimura; Kensaku Shibazaki; Junya Aoki Background: Our aim was to investigate the relationship between the number of stroke physicians (SPs) and management of intravenous thrombolysis using recombinant tissue plasminogen activator (IV rt-PA) in Japan. Methods: Questionnaires...
M. Köhrmann, T. Nowe, H.B. Huttner, T. Engelhorn, T. Struffert, R. Kollmar, M. Saake, A. Doerfler, S. Schwab, P.D. Schellinger
Cerebrovasc Dis (2009) 27 (2): 160–166.
Published Online: 18 December 2008
.... Intravenous thrombolysis Minor stroke Plasminogen activator rt-PA Stroke scores Thrombolytic therapy The proportion of patients with acute ischemic stroke receiving recombinant tissue-type plasminogen activator (rt-PA) remains low [ 1 ]. The most important reason for this is the narrow and early...
Danilo Toni, Svetlana Lorenzano, Giancarlo Agnelli, Donata Guidetti, Giovanni Orlandi, Andrea Semplicini, Vito Toso, Valeria Caso, Giovanni Malferrari, Simona Fanucchi, Luigi Bartolomei, Massimiliano Prencipe
Cerebrovasc Dis (2008) 25 (1-2): 129–135.
Published Online: 11 December 2007
...Danilo Toni; Svetlana Lorenzano; Giancarlo Agnelli; Donata Guidetti; Giovanni Orlandi; Andrea Semplicini; Vito Toso; Valeria Caso; Giovanni Malferrari; Simona Fanucchi; Luigi Bartolomei; Massimiliano Prencipe Background: Intravenous (i.v.) thrombolysis with rt-PA within 3 h from symptom onset...
Thorsten Steiner, Erich Bluhmki, Markku Kaste, Danilo Toni, Paul Trouillas, Rüdiger von Kummer, Werner Hacke
Cerebrovasc Dis (1998) 8 (4): 198–203.
Published Online: 06 July 1998
... of thrombolytic therapy using recombinant tissue plasminogen activator (rt-PA) in acute ischemic stroke. (2) To discuss the results of the ECASS 0- to 3-hour cohort with the results of the National Institute of Neurological Disorders and Stroke Study (NINDSS). Design and Analysis: Analysis of the 0- to 3-hour...
Cerebrovasc Dis (1998) 8 (3): 166–171.
Published Online: 24 April 1998
... supratentorial stroke within 3 h after symptom onset with rt-PA following a protocol similar to the NINDS study. The results of thrombolytic therapy were evaluated by repeated clinical examination and computed tomography (CT) during the first week after ictus. The incidence of space-occupying brain edema...